Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/163876 |
Resumo: | Colon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications. |
id |
RCAP_98f0b9bc926e90bbf57caa7240e06c19 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/163876 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activityColon cancer5-fluorouracil (5-FU)liposomesiron oxide nanoparticles (MNPs)antiproliferative activitymagnetic propertiesDomínio/Área Científica::Engenharia e Tecnologia::NanotecnologiaColon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications.O cancro do cólon (CC) é o quarto tipo de cancro mais frequente e a quinta principal causa de morte relacionada com o cancro a nível mundial. A maioria dos casos é diagnosticada numa fase tardia, o que leva à necessidade de tratamentos mais agressivos, como a quimioterapia. O 5-Fluorouracil (5-FU), conhecido pelas suas propriedades citotóxicas contra as células tumorais, surgiu como um agente qui-mioterapêutico viável. No entanto, apresenta vários inconvenientes, como a falta de especificidade ou um tempo de vida curto. Para reduzir estes efeitos secundários, o composto pode ser incorporado em drug delivery systems (DDS), permitindo tempos de circulação mais longos e um direcionamento e li-bertação preferenciais nos locais tumorais. A presente investigação centrou-se no desenvolvimento de um sistema híbrido, combinando propriedades terapêuticas e magnéticas. Para este efeito, 5-FU foi in-corporado em lipossomas de longa circulação sanguínea simultaneamente com nanopartículas de ferro (MNPs). A incorporação ativa foi considerada o melhor método para preparar os lipossomas de 5-FU, estabelecendo um gradiente de sulfato de amónio entre os meios intra e extralipossomais. Os lipossomas vazios foram preparados pela técnica de desidratação-reidratação, seguida de um passo de extrusão para reduzir e homogeneizar o seu tamanho médio, seguido de filtração em gel para estabelecer o gradiente de sulfato de amónio. A caraterização destas formulações foi efetuada em termos de parâmetros de incorporação, diâmetro médio e carga superficial. Estudos in vitro confirmaram que a atividade antipro-liferativa do 5-FU contra uma linha celular de cancro do cólon foi preservada após a incorporação em lipossomas, enquanto as MNPs não exibiram propriedades citotóxicas. Além disso, foi demonstrado que a presença destas nanopartículas conferiu propriedades magnéticas aos lipossomas, permitindo-lhes res-ponder a campos magnéticos externos. Em suma, um nanosistema lipídico que incorpora um agente quimioterapêutico e com características magnéticas foi desenvolvido com sucesso e caracterizado fí-sico-quimicamente, para futuras aplicações in vivo.Gaspar, Maria ManuelaBorges, JoãoSoares, PaulaRUNAzevedo, Afonso Toledo2024-02-21T15:44:40Z2023-112023-11-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/163876enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:49:12Zoai:run.unl.pt:10362/163876Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:59:53.528382Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
title |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
spellingShingle |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity Azevedo, Afonso Toledo Colon cancer 5-fluorouracil (5-FU) liposomes iron oxide nanoparticles (MNPs) antiproliferative activity magnetic properties Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
title_short |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
title_full |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
title_fullStr |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
title_full_unstemmed |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
title_sort |
Validation of a novel hybrid nanosystem integrating cytotoxic and magnetic properties as a tool to potentiate the antitumor activity |
author |
Azevedo, Afonso Toledo |
author_facet |
Azevedo, Afonso Toledo |
author_role |
author |
dc.contributor.none.fl_str_mv |
Gaspar, Maria Manuela Borges, João Soares, Paula RUN |
dc.contributor.author.fl_str_mv |
Azevedo, Afonso Toledo |
dc.subject.por.fl_str_mv |
Colon cancer 5-fluorouracil (5-FU) liposomes iron oxide nanoparticles (MNPs) antiproliferative activity magnetic properties Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
topic |
Colon cancer 5-fluorouracil (5-FU) liposomes iron oxide nanoparticles (MNPs) antiproliferative activity magnetic properties Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
description |
Colon cancer (CC) is the fourth most frequent type of cancer and the fifth leading cause of cancer-related deaths worldwide. The majority of cases are diagnosed at a later stage, leading to the need for more aggressive treatments such as chemotherapy. 5-Fluorouracil (5-FU), known for its cytotoxic prop-erties against tumor cells, has emerged as a viable chemotherapeutic agent. However, it presents several drawbacks such as lack of specificity or short half-life. To reduce these drawbacks, the chemotherapeu-tic compound can be incorporated into drug delivery systems (DDS), allowing longer circulation times and preferential targeting and release at the tumor sites. The current research was focused on the devel-opment of a hybrid delivery system, combining both therapeutic and magnetic properties. For this pur-pose, 5-FU was loaded in long blood circulation liposomes (DMPC:Chol:DSPE-PEG) simultaneously with iron oxide nanoparticles (MNPs). Remote loading was found to be the best method for incorporat-ing 5-FU in nanoliposomes by establishing an ammonium sulphate gradient. Unloaded liposomes were prepared by the dehydration-rehydration technique, followed by an extrusion step to reduce and homog-enize their mean size followed by a gel filtration to establish the ammonium sulfate gradient. The char-acterization of the developed nanoformulations was done in terms of incorporation parameters, mean size and surface charge. In vitro studies confirmed that 5-FU antiproliferative activity, towards a murine colon cancer (CT-26) cell line, was preserved after incorporation in liposomes while the MNPs did not exhibit cytotoxic properties. Additionally, the presence of MNPs was shown to confer magnetic prop-erties to the liposomes, allowing them to respond to external magnetic fields. Moreover, the liposomal formulations were characterized by transmission electron microscopy (TEM). In sum, a lipid nanosys-tem loading a chemotherapeutic agent and displaying magnetic characteristics was successfully de-signed and physiochemically characterized, for further in vivo applications. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-11 2023-11-01T00:00:00Z 2024-02-21T15:44:40Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/163876 |
url |
http://hdl.handle.net/10362/163876 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138175150456832 |